Cellectis S.A. (CLLS)

Cellectis Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	203.82	89.79	185.64	241.15	340.52
Short-Term Investments	67.11	7.91	0.5	27.09	20.39
Cash & Cash Equivalents	270.92	97.7	186.14	268.24	360.91
Cash Growth	177.31%	-47.51%	-30.61%	-25.68%	-20.13%
Receivables	21.47	15.27	29.63	15.87	12.1
Inventory	0	0	0	1.61	2.9
Other Current Assets	-59.39	9.08	9.67	29.64	15.62
Total Current Assets	233.01	122.04	225.43	315.36	391.52
Property, Plant & Equipment	92.74	107.9	148.27	145.52	69.32
Long-Term Investments	7.85	8.79	6.52	7.01	0
Goodwill and Intangibles	0.67	0.72	1.85	1.58	1.11
Other Long-Term Assets	0	21.77	0	0	5.52
Total Long-Term Assets	101.27	139.17	156.65	154.11	75.95
Total Assets	334.27	261.22	382.08	469.47	467.47
Accounts Payable	19.07	21.46	23.76	24.61	29.26
Deferred Revenue	110.33	0.06	0.3	0.45	20.03
Current Debt	13.79	12.96	10.68	6.7	1.07
Other Current Liabilities	11.96	13.66	14.6	20.26	12.24
Total Current Liabilities	155.14	48.13	49.35	52.02	62.6
Long-Term Debt	92.07	69.89	91.56	104.6	46.54
Other Long-Term Liabilities	2.36	17.26	4.7	4.01	2.86
Total Long-Term Liabilities	94.43	87.14	96.25	108.61	49.4
Total Liabilities	249.58	135.28	145.6	160.63	112
Total Debt	105.86	82.85	102.24	111.3	47.61
Debt Growth	27.78%	-18.97%	-8.14%	133.78%	3423.83%
Retained Earnings	-405.77	-439.5	-698.33	-587.04	-508.48
Comprehensive Income	-36.69	-28.61	-18.02	-4.09	-22.64
Shareholders' Equity	84.7	117.97	221.29	283.8	315.12
Net Cash / Debt	165.06	14.85	83.9	156.94	313.3
Net Cash / Debt Growth	1011.73%	-82.30%	-46.54%	-49.91%	-30.46%
Net Cash Per Share	2.90	0.33	1.87	-	-
Working Capital	77.86	73.91	176.08	263.35	328.92
Book Value Per Share	1.49	2.59	4.94	6.68	7.43

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).